title: Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs.
abstract: We assessed the performance of REMA in comparison with BACTEC MGIT 960 in the susceptibility testing of 80 Mycobacterium tuberculosis clinical isolates from Clemente Ferreira Institute against four drugs. REMA proved to be a rapid and accurate method, providing excellent correlation with BACTEC MGIT 960, with the exception of results for the ethambutol drug.
authors.affiliation: Universidade Estadual Paulista, Faculdade de Ciências Farmacêuticas, Araraquara, SP, Brazil.
authors.forename: Marcelo
authors.initials: M
authors.lastname: Miyata
authors.forename: Fernando Rogério
authors.initials: FR
authors.lastname: Pavan
authors.forename: Daisy Nakamura
authors.initials: DN
authors.lastname: Sato
authors.forename: Leonardo Biancolino
authors.initials: LB
authors.lastname: Marino
authors.forename: Mario Hiroyuki
authors.initials: MH
authors.lastname: Hirata
authors.forename: Rosilene Fressati
authors.initials: RF
authors.lastname: Cardoso
authors.forename: Fernando Augusto Fiúza
authors.initials: FA
authors.lastname: de Melo
authors.forename: Clarice Queico Fujimura
authors.initials: CQ
authors.lastname: Leite
keywords: Mycobacterium tuberculosis; drug susceptibility testing; tuberculosis